Thomas J. Kottarathil

Thomas Kottarathil practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Thomas Kottarathil's NPI, 1205911997, was assigned on October 25, 2006. Thomas Kottarathil holds Utah license 323614-1205.

Thomas Kottarathil's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Thomas Kottarathil's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Thomas Kottarathil is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Community Physicians Group. Dmand AI also links Thomas Kottarathil to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thomas Kottarathil practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Thomas Kottarathil's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Thomas Kottarathil is licensed in Utah.

CMS data shows 358 Medicare services from Thomas Kottarathil across 4 procedure codes in 2024, for 201 Medicare patients. Medicare paid $23,595 for them. Every service was in an office.

CMS counts 201 Medicare patients who saw Thomas Kottarathil in 2024. The largest group is 65 to 74, with 81 patients. 70% of them have high blood pressure, and 44% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Thomas Kottarathil's median patient age at 68, with 44% women.

In 2024, Thomas Kottarathil wrote 10,105 Medicare Part D claims for 644 patients. 85% of them were for generic drugs. CMS names the drug for 9,271 of them, across 136 drugs with 11 or more claims each, at $997,813 in total drug cost. In 2023, CMS named 9,564 claims across 140 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Thomas Kottarathil for performance year 2024, reported as part of a group. Thomas Kottarathil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Thomas Kottarathil as offering telehealth.

CMS Open Payments shows 2 general payments to Thomas Kottarathil from 2 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Dexcom, Inc. paid the most, $108.